ALPMY News and Press, Astellas Pharma Inc. ADR From 09/14/23

Astellas to Invest more than €330 Million in a New State-of-the-Art Facility in Tralee, Co. Kerry. Ireland PR Newswire - Investment will build capabilities to supply the Astellas global market and accelerate the development and commercialisation of innovative medicines ...

European Medicines Agency Validates Type II Variation for Astellas' XTANDI® (enzalutamide) for Treatment of Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence PR Newswire Application based on results from Phase 3 EMBARK trial, which sho...

2023-08-23 08:12:30 ET More on Pfizer Pfizer Stock: The Right Time To Buy Now (Technical Analysis) Pfizer: Doubling Down Buying Opportunity Is Here Pfizer's Unexpected Strength: Bullish Case Emerges Amid New Covid-19 Wave Pfizer Inc. ( PFE ) Q2 2023 Ear...

FDA Grants Priority Review for XTANDI® in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence PR Newswire If approved, XTANDI would become the first and only novel hormone therapy approved in this earlier type of prostate cancer ...

European Medicines Agency Accepts Iveric Bio's Marketing Authorization Application for Avacincaptad Pegol for Geographic Atrophy PR Newswire TOKYO , Aug. 18, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura , "Astell...

2023-08-16 12:41:31 ET Summary Astellas has closed its Iveric bio, Inc. deal in July and reported JPY 375Bn in quarterly sales in Q1. The company's earnings power and asset factors are bullish, but valuation factors are keeping me neutral. From this, I am closely watching the ...

2023-08-14 07:55:03 ET Summary George Soros's 13F portfolio value decreased slightly from $6.49B to $6.41B, with 172 positions. New stakes include PDC Energy, IVERIC bio, ARK Innovation ETF Calls, Alibaba Group Holding, Five9 Puts, RenaissanceRE Holdings, and MicroStrategy Puts. ...

2023-08-14 07:00:00 ET Summary Biotech stocks faced challenges in the first half of the year, with the Nasdaq Biotechnology Index losing 3%, compared to strong advances in the broader market. The direction of the 10-year bond yield has become a key predictor of biotech industry pe...

Astellas to Open New Life Sciences Facility in DivcoWest's Cambridge Crossing Neighborhood PR Newswire TOKYO and SAN FRANCISCO , Aug. 9, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura , "Astellas") and Divco...

2023-08-07 13:54:42 ET More on Apellis Apellis: Exercise Caution In Response To Safety Signal (Rating Downgrade) Apellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition Space Apellis extends selloff as JPMorgan becomes latest to downgrade Apellis off ...